Insider Transactions in Q3 2024 at Foghorn Therapeutics Inc. (FHTX)
Insider Transaction List (Q3 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 23
2024
|
Carlos Costa Chief People Officer |
SELL
Open market or private sale
|
Direct |
857
-100.0%
|
$8,570
$10.17 P/Share
|
Sep 23
2024
|
Carlos Costa Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
857
+50.0%
|
$2,571
$3.72 P/Share
|
Sep 20
2024
|
Carlos Costa Chief People Officer |
SELL
Open market or private sale
|
Direct |
35,756
-100.0%
|
$357,560
$10.04 P/Share
|
Sep 20
2024
|
Carlos Costa Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
35,756
+50.0%
|
$107,268
$3.72 P/Share
|
Sep 18
2024
|
Carlos Costa Chief People Officer |
SELL
Open market or private sale
|
Direct |
11,574
-100.0%
|
$115,740
$10.05 P/Share
|
Sep 18
2024
|
Carlos Costa Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,574
+50.0%
|
$34,722
$3.72 P/Share
|
Sep 17
2024
|
Carlos Costa Chief People Officer |
SELL
Open market or private sale
|
Direct |
10,272
-100.0%
|
$102,720
$10.04 P/Share
|
Sep 17
2024
|
Carlos Costa Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,272
+50.0%
|
$30,816
$3.72 P/Share
|
Sep 16
2024
|
Carlos Costa Chief People Officer |
SELL
Open market or private sale
|
Direct |
400
-100.0%
|
$4,000
$10.0 P/Share
|
Sep 16
2024
|
Carlos Costa Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
400
+50.0%
|
$1,200
$3.72 P/Share
|
Sep 09
2024
|
Steven F. Bellon Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
20,000
-16.4%
|
$180,000
$9.5 P/Share
|